health careMarket Research NewsNewsSmart gadgets

Internal Neuromodulation Device Market 2019 | Report Forecasting $12.18 Billion Growth by 2024 | Medtronic, Boston Scientific Corporation, St. Jude Medical, Nevro Corporation, Cyberonics

This Internal Neuromodulation device market report helps to identify trends in consumer and supply chain dynamics and accordingly interpret marketing, promotional and sales strategies for business growth and an utmost success. This market report aids in developing a successful marketing strategy for your business. Internal Neuromodulation Device market report has been prepared based on detailed market analysis with inputs from industry experts. It includes historic data, present market trends, environment, technological innovation, upcoming technologies and the technical progress in the related industry. Internal Neuromodulation Device market research report gives you maximum benefits to grow your business.

With a systematic problem analysis, model building and fact-finding, Internal Neuromodulation Device market report helps businesses in decision-making and managing marketing of goods and services. The data and the information regarding healthcare industry are taken from reliable sources such as websites, annual reports of the companies, and journals etc. and were checked and validated by the market experts. Internal Neuromodulation Device report provides statistics on the current state of the industry as a valuable source of guidance and direction for companies and investors interested in this market. This is the most relevant, unique, fair and creditable global market research report which suits your business needs.

Market Analysis:

The Global Internal Neuromodulation Device Market is expected to reach USD  12.18 billion by 2024, from 4.12 billion in 2016 growing at the CAGR of 14.5% in the forecast period 2017 to 2024.

Download Free Sample Report @ https://databridgemarketresearch.com/request-a-sample/?dbmr=global-internal-neuromodulation-devices-market

FACTORS DRIVING GROWTH OF THE GLOBAL INTERNAL NEUROMODULATION DEVICES MARKET

Increasing prevalence of neurological diseases:

According to the Alzheimer’s Association in 2017, 5.5 million Americans had Alzheimer and about 5.3 million of this patient population’s age was 65 years or more. According to Alzheimer disease international, in 2015 there were an estimated 46.8 million people living with Alzheimer worldwide this number is expected to be double every 20 years reaching 75 million in 2030 and 131.5 million by 2050.

According to national center for biotechnology information, about 60,000 Americans are diagnosed with Parkinson’s every year. An estimated 7 million to 10 million people worldwide have Parkinson’s disease. The prevalence of this disease is 1,900 per 100,000 in those who are above 80 years of age and 41 per 100,000 in fourth decade of life.

Epilepsy is the chronic disorder of the brain which affects almost all ages. According to world health organization, 50 million people worldwide have epilepsy and this number is estimated to increase in coming years which makes it one of the most common neurological disorders.

Therefore, with the increase in disease condition such as Alzheimer’s, Parkinson’s, epilepsy, eschemia, the global internal neuromodulation devices market is expected to achieve a growth in future.

  • Medtronic
  • Boston Scientific Corporation
  • Abbott
  • Nevro Corp
  • Cyberonics, Inc.
  • Neuros Medical
  • Inspire Medical Systems, Inc
  • SPR Therapeutics
  • Synapse Biomedical Inc
  • NeuroSigma Inc
  • NeuroPace Inc.
  • Neuronetics
  • BioControl Medical
  • Soterix Medical Inc
  • DynaMD
  • Integer Holdings Corporation
  • LivaNova PLC
  • Bioness Inc
  • ReShape Lifesciences.Inc

Get Detailed TOC @ https://databridgemarketresearch.com/toc/?dbmr=global-internal-neuromodulation-devices-market

Global Internal Neuromodulation Devices Market– Segmentation:

The global market for internal neuromodulation devices by the following sub-categories is presented

By Product Type

  • Spinal Cord Stimulator
  • Deep Brain Stimulator
  • Vagus Nerve Stimulator
  • Sacral Nerve Stimulator
  • Gastric Nerve Stimulator

By Indication of Usage

  • Failed Back Surgery Syndrome
  • Conditional Regional Pain Syndrome
  • Eschemia
  • Parkinson’s Disease
  • Alzheimers
  • Urinary Incontinence
  • Faecal Incontinenece
  • Epilepsy
  • Gastroparesis
  • Others

By Lead Type

  • Percutaneous
  • Paddle Lead

By Battery Type

  • Primary
  • Rechargeable

By Geography

  • North America
  • South America
  • Europe
  • Asia-Pacific
  • Middle East and Africa

Speak To Author https://databridgemarketresearch.com/speak-to-analyst/?dbmr=global-internal-neuromodulation-devices-market

Tags

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Close